6ZIE
Crystal structure of MCL-1 in complex with a neutralizing Alphabody CMPX-383B
6ZIE の概要
| エントリーDOI | 10.2210/pdb6zie/pdb |
| 分子名称 | CMPX-383B, Induced myeloid leukemia cell differentiation protein Mcl-1, ZINC ION, ... (4 entities in total) |
| 機能のキーワード | de novo protein design, 3 helical antiparallel coiled coil, cell penetrating alphabody mcl-1 neutralizing alphabody, antitumor protein |
| 由来する生物種 | synthetic construct 詳細 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 33627.94 |
| 構造登録者 | Pannecoucke, E.,Savvides, S.N.,Desmet, J.,Lasters, I. (登録日: 2020-06-25, 公開日: 2021-04-28, 最終更新日: 2024-11-20) |
| 主引用文献 | Pannecoucke, E.,Van Trimpont, M.,Desmet, J.,Pieters, T.,Reunes, L.,Demoen, L.,Vuylsteke, M.,Loverix, S.,Vandenbroucke, K.,Alard, P.,Henderikx, P.,Deroo, S.,Baatz, F.,Lorent, E.,Thiolloy, S.,Somers, K.,McGrath, Y.,Van Vlierberghe, P.,Lasters, I.,Savvides, S.N. Cell-penetrating Alphabody protein scaffolds for intracellular drug targeting. Sci Adv, 7:-, 2021 Cited by PubMed Abstract: The therapeutic scope of antibody and nonantibody protein scaffolds is still prohibitively limited against intracellular drug targets. Here, we demonstrate that the Alphabody scaffold can be engineered into a cell-penetrating protein antagonist against induced myeloid leukemia cell differentiation protein MCL-1, an intracellular target in cancer, by grafting the critical B-cell lymphoma 2 homology 3 helix of MCL-1 onto the Alphabody and tagging the scaffold's termini with designed cell-penetration polypeptides. Introduction of an albumin-binding moiety extended the serum half-life of the engineered Alphabody to therapeutically relevant levels, and administration thereof in mouse tumor xenografts based on myeloma cell lines reduced tumor burden. Crystal structures of such a designed Alphabody in complex with MCL-1 and serum albumin provided the structural blueprint of the applied design principles. Collectively, we provide proof of concept for the use of Alphabodies against intracellular disease mediators, which, to date, have remained in the realm of small-molecule therapeutics. PubMed: 33771865DOI: 10.1126/sciadv.abe1682 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.3 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






